Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 4, 1998, Pages 921-927

  Bice Jr , William S ^a,b   Prestidge, Bradley R ^a   Grimm, Peter D ^c   Friedland, Jay L ^d   Feygelman, Vladimir ^d   Roach III, MacK ^e   Prete, James J ^a,b   Dubois, Donald F ^b   Blasko, John C ^f  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Northwest Prostate Institute   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Brachytherapy; Implant; Iodine; Prostate; Quality

Indexed keywords

IODINE 125;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; DRUG IMPLANTATION; ECHOGRAPHY; INTERSTITIAL RADIATION; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; RADIATION DOSE; RADIATION RESPONSE; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME;

EID: 0344222165     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)90123-7     Document Type: Article

References (23)

1. Prestidge B.R., Prete J.J., Buchholz T.A., Friedland J.L., Stock R.G., Grimm P.D., Bice W.S. A survey of current clinical practice of permanent prostate brachytherapy in the United States. Int. J. Radiat. Oncology Biol. Phys. 40:1998;461-465.
2. 125iodine implantation for stage T1/T2 prostatic carcinoma. J. Urol. 154:1995;1096-1099.
3. Blasko J.C., Ragde H., Schumacher D. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endocuriether/Hyperthermia Oncol. 3:1987;131-139.
4. Blasko J.C., Grimm P.D., Ragde H. Brachytherapy and organ preservation in the management of carcinoma of the prostate. Semin. Radiat. Oncol. 3:1993;240-249.
5. Grimm P.D., Blasko J.C., Ragde H. Ultrasound-guided transperineal implantation of iodine-125 and palladium-103 for the treatment of early-stage prostate cancer. Atlas Urol. Clin. North Am. 2:1994;113-125.
6. Roberson P.L., Narayana V., McShan D.L., Winfield R.J., McLaughlin P.W. Source placement error for permanent implant of the prostate. Med. Phys. 24:1997;251-257.
7. Stone N.N., Ramin S.A., Wesson M.F., Stock R., Unger P., Klein G. Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate. J. Urol. 153:1995;1555-1560.
8. 125iodine prostate implants. J. Urol. 146:1991;90-95.
9. Nath R., Anderson L.L., Luxton G., Weaver K.A., Williamson J.F., Meigooni A.S. Dosimetry of interstitial brachytherapy sources Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 . Med. Phys. 222:1995;209-234.
10. International Commission on Radiation Units and Measurements Report No. 38, dose and volume specification for reporting intracavitary therapy in gynecology. Bethesda, MD: ICRU Publications; 1985.
11. International Commission on Radiation Units and Measurements Report No. 58, Untitled. Bethesda, MD: ICRU Publications; (submitted for publication).
12. Bice W.S., Prestidge B.P. A review of post-implant quality assessment in permanent transperineal interstitial prostate brachytherapy. J. Brachyther. Int. 13:1997;297-313.
13. Roy J.N., Wallner K.E., Harrington B.A., Ling C.C., Anderson L.L. A CT-based evaluation method for permanent implants Application to prostate . Int. J. Radiat. Oncol. Biol. Phys. 26:1993;163-169.
14. Saw C.B., Suntharalingam N. Quantitative assessment of interstitial implants. Int. J. Radiat. Oncol. Biol. Phys. 201:1991;135-139.
15. 125I transperineal prostate seed implants on commercial treatment planning systems. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;737-741.
16. Stone N.N., Stock R.G., DeWyngaert J.K., Tabert A. Prostate brachytherapy Improvements in prostate volume measurements and dose distribution using interactive ultrasound guided implantation and three-dimensional dosimetry . Radiat. Oncol. Invest. 3:1995;185-195.
17. Prestidge B.P., Bice W.S., Kieffer E.J., Prete J.J. Timing of CT-based post implant assessment following permanent transperineal prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;1111-1115.
18. Waterman F.M., Yue N., Reisinger S., Dicker A., Corn B.W. Effect of edema on the post-implant dosimetry of an I-125 prostate implant A case study . Int. J. Radiat. Oncol. Biol. Phys. 38:1997;335-339.
19. Stock R.G., Stone N.N., DeWyngaert J.K., Lavagnini P., Unger P.D. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer. 77:1996;2386-2392.
20. Dubois D.F., Prestidge B.R., Hotchkiss L.A., Prete J.J., Bice W.S. Source localization using magnetic resonance imaging following permanent transperineal prostate interstitial brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 39:1997;1037-1041.
21. Roach M., Faillace-Akazawa P., Malfatti C., Holland J., Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;1011-1018.
22. Terris M.K., Stamey T.A. Determination of prostate volume by transrectal ultrasound. J. Urol. 145:1991;984-987.
23. Tewari A. Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia. J. Clin. Ultrasound. 24:1996;169-174.